Ispire Technology Inc. (NASDAQ:ISPR) shares dived Wednesday. The Los Angeles-based company, an innovator in vaping technology and precision dosing, today reported financial results for the fourth quarter and fiscal year ended June 30, 2026.
President Steven Przybyla commented, "We believe fourth-quarter results mark an important inflection point for the company and the turnaround we began more than a year ago. Fourth-quarter revenue increased 33% year-over-year and 43% sequentially to $26.7 million, while operating cash flow also increased sequentially.
Revenue was $26.7 million, compared to $20.1 million in the fourth quarter of fiscal year 2025. The increase of $6.6 million, or 32.5%.
Net loss was $13.8 million, or ($0.24) per share, an improvement of $971,000 compared to a net loss of $14.8 million, or ($0.26) per share, in the fourth quarter of fiscal year 2025.
Przybyla once again, “In our view, these results demonstrate that the restructuring and investments we have made are beginning to translate into improved operating performance and position us for a fundamentally improved fiscal 2027. Our Malaysia manufacturing facility is now fully operational, our Vapor ODM platform is entering the market, and we continue to advance IKE Tech's proprietary age-gating technology toward commercialization.
“We have also begun to expand beyond vaping through our joint venture with Jincheng Pharma, giving us a platform to enter the rapidly growing nicotine pouch market.”
ISPR shares dipped 14 cents, or 9.7%, to $1.30.
Tech Insider
